Brett Jorgensen

1.6k citations
13 papers · 499 indexed · h-index 8
Topics
Monoclonal and Polyclonal Antibodies Research (8 papers)CAR-T cell therapy research (6 papers)Glycosylation and Glycoproteins Research (3 papers)

In The Last Decade

Brett Jorgensen

13 papers receiving 487 citations

Peers

Brett Jorgensen
Comparison fields: 5 of 69
  • Oncology 270
  • Molecular Biology 169
  • Radiology, Nuclear Medicine and Imaging 157
  • Immunology 109
  • Cancer Research 96
Replace Yuichi Yakata with:
Yuichi Yakata Japan
Jussi P. Elo Finland
Y Uenoyama Japan
Hae Hyun Jung South Korea
Jingmei Su China
Xiaoyi Zhang China
Chrissta X. Maracle Netherlands
Li‐Hwa Wu Taiwan
Donald P. Lesslie United States
Brett Jorgensen relative to Yuichi Yakata Japan Yuichi Yakata's profile →
Citations per field
00.5×4.9×
Yuichi Yakata · 1×
Citations per year

Countries citing papers authored by Brett Jorgensen

Since Specialization
Citations

This map shows the geographic impact of Brett Jorgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Jorgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Jorgensen more than expected).

Fields of papers citing papers by Brett Jorgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Jorgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Jorgensen. The network helps show where Brett Jorgensen may publish in the future.

Co-authorship network of co-authors of Brett Jorgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Jorgensen. A scholar is included among the top collaborators of Brett Jorgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Jorgensen. Brett Jorgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 22
2 6
3 82
4 2
5 4
6 2
7 7
8 165
9 10
10 28
11 33
12 88
13 50

About Brett Jorgensen

Brett Jorgensen is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 13 papers that have together received 499 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), CAR-T cell therapy research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Oncology (270 citations), Pharmacology (66 citations) and Radiology, Nuclear Medicine and Imaging (157 citations). Brett Jorgensen has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Peter I. Mackenzie, Philip A. Gregory, Rikke Lewinsky, Wen Xie, Dione Gardner-Stephen, Carlos García, Vivian Barry-Hamilton, Amanda Mikels‐Vigdal, Derek Marshall and Ruth Wang. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026